Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial, page-196

I sense Paul’s approach with the agencies and big pharma is one of consensus building. Consensus amongst the scientific community/agencies/big pharma.

He knows what we have under the hood. We are presenting a solution to a wealthy, educated 1st world ageing population and the agencies don’t a anything like what we have.

He/We don’t have to do anything else except present the data. All we need to do is get out of the way and let the team go to work. I think some quiet skepticism is normal. But I sense our man has it at hand.